Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma (Q41726331)

8 October 2017

title

Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma (English)

1 reference

8 October 2017

0 references

Malini D Sur

1

1 reference

8 October 2017

Haejin In

2

1 reference

8 October 2017

Susan M Sharpe

3

1 reference

8 October 2017

Marshall S Baker

4

1 reference

8 October 2017

Ralph R Weichselbaum

5

1 reference

8 October 2017

Mark S Talamonti

6

1 reference

8 October 2017

Mitchell C Posner

7

1 reference

8 October 2017

publication date

5 December 2014

1 reference

Annals of Surgical Oncology

8 October 2017

published in

1 reference

8 October 2017

volume

22

1 reference

8 October 2017

issue

7

1 reference

8 October 2017

page(s)

2209-2217

1 reference

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Combined resection of the liver and inferior vena cava for hepatic malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Intrahepatic cholangiocarcinoma: management options and emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Multidisciplinary approaches to intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

A proposed staging system for intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Cancer recurrence: an important but missing variable in national cancer registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Factors affecting survival after resection of intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4275-4

10.1245/S10434-014-4275-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

1008286266

0 references

1 reference